Congress quietly subsidizes dietary supplements for the HSA-eligible few

What it does

This bill allows people to use pre-tax health savings accounts (HSAs), Archer MSAs, and flexible spending arrangements to pay for dietary supplements up to $500 per year ($250 if married filing separately), treating them as qualified medical expenses. The bill defines dietary supplements using the federal Food, Drug, and Cosmetic Act definition and explicitly excludes energy drinks, sodas, and soft drinks.

Why we flagged it

The bill's core mechanism is a targeted tax benefit—allowing pre-tax health savings accounts to cover dietary supplements up to $500/year. This is a straightforward tax expenditure that reduces revenue and benefits supplement purchasers with access to these accounts.

What the text implies

• The $500 annual cap applies per account type (HSA, Archer MSA, FSA/HRA), potentially allowing individuals with multiple account types to exceed $500 total in tax-subsidized supplement purchases.
• The definition of 'dietary supplement' relies on the Federal Food, Drug, and Cosmetic Act, which has a broad definition that includes many products with minimal clinical evidence of efficacy.
• Tax-subsidizing supplements may create implicit government endorsement of products that lack rigorous FDA approval, potentially misleading consumers about safety and efficacy.
• The benefit is regressive: only workers with employer-sponsored HSAs or FSAs can use it, excluding self-employed individuals and those without such plans, concentrating the benefit among higher-income workers.

Who it affects

The bill provides a modest tax benefit to people with HSAs and flexible spending accounts who purchase dietary supplements, reducing their out-of-pocket costs. However, the benefit is limited to higher-income workers who have access to these accounts, and the $500 annual cap is modest. The broader public interest is unclear: dietary supplements are largely unregulated and of uncertain medical value, so subsidizing them via tax-preferred accounts may not represent a sound public health investment

Who stands to gain

• dietary supplement manufacturers and retailers
• HSA/FSA account administrators
• workers with access to employer-sponsored health savings accounts

Named in the bill

Internal Revenue Code Section 223 (HSAs), Internal Revenue Code Section 220 (Archer MSAs), Internal Revenue Code Section 106 (FSAs/HRAs), Federal Food, Drug, and Cosmetic Act Section 201, dietary supplement industry

Where it stands

1 cosponsor: 1 Republicans.

• May 20, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• May 20, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 5 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $489,750 in lobbying spend. A filing names 7 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Kevin Cramer, the sponsor, reported $204,312 in PAC receipts in the 2026 cycle.

• Consumer Healthcare Products Association — $199,750 on 1 filing
• Unilever United States, Inc. — $130,000 on 1 filing
• Council for Responsible Nutrition — $100,000 on 1 filing
• Health-e Commerce Including Subsidiaries — $40,000 on 1 filing
• American Herbal Products Association — $20,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.